Gα13 restricts nutrient driven proliferation in mucosal germinal centers.

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Germinal centers (GCs) in mucosal sites interact with gut factors influencing immune homeostasis.
• The G-protein Gα13 plays a role in confining B cells within GCs and suppressing GC-derived lymphoma.
• Dysregulation of GC processes can contribute to the development of gastrointestinal lymphomas.

Purpose of the Study:

• To investigate the role of Gα13 in regulating GC reactions within the mesenteric lymph node (mLN).
• To determine how Gα13 deficiency impacts B cell behavior and nutrient utilization in mucosal GCs.
• To elucidate the mechanisms by which Gα13 pathway mutations promote gut-associated lymphoma.

Main Methods:

• Analysis of Gα13-deficient mice to study GC B cell behavior in the mLN.
• Assessment of mTORC1 signaling and Myc protein expression in GCs.
• Investigation of the dependence of Gα13-deficient GC B cells on dietary nutrients, particularly glutamine.

Main Results:

• Gα13 deficiency enhances GC reactions in the mLN through increased mTORC1 signaling and Myc expression.
• Gα13-deficient GC B cells exhibit a competitive advantage independent of T cell help or gut microbiota.
• Diet-derived glutamine selectively supports proliferation and Myc expression in Gα13-deficient GC B cells within the mLN.

Conclusions:

• GC confinement by Gα13 normally limits the impact of dietary nutrients like glutamine on mucosal GC dynamics.
• Gα13 deficiency disrupts this confinement, leading to nutrient-driven GC expansion and increased lymphoma risk.
• Gα13 pathway mutations may hijack these nutrient-sensing mechanisms to promote the gut tropism of aggressive lymphomas.